Research Shows iPS-ML/IFN-β Migrates to, Penetrate Liver Cancer Tumors

There is therapeutic potential for iPS-ML/IFN-β in patients with liver cancer, but more research is needed.
There is therapeutic potential for iPS-ML/IFN-β in patients with liver cancer, but more research is needed.

A type of cell called induced pluripotent stem (iPS)-myeloid lineage (iPS-ML) can produce interferon-β (IFN-β), which can fight primary and metastatic liver cancer, according to results from research on a mouse xenograft model of liver cancer.

First, researchers generated a murine xenograft model of liver metastasis by injecting the spleen of mice with severe combined immunodeficiency (SCID) with MKN-45 human gastric cancer cells. They also generated a primary liver cancer model by injecting SK-HEP-1 human hepatocellular carcinoma (the most common type of liver cancer) cells directly into the liver.

Once cancer lesions were established, researchers administered iPS-ML/IFN-β by intraperitoneal injection and then evaluated the potential therapeutic effect.

Injection of iPS-ML/IFN-β resulted in significant decreases in tumor progression and significantly increased mouse survival. Researchers observed infiltration of iPS-ML into tumors beneath the liver capsule, which indicates tumor-directed migration and penetration by iPS-ML.

Concentrations of IFN-β were high enough to exert anticancer effects for a minimum of 3 days after injection. This extended anticancer effect accounts for the strong therapeutic benefit from injections 2 to 3 times per week.

These results suggest a therapeutic potential for iPS-ML/IFN-β in patients with liver cancer, although additional research is needed.

Reference

1. Sakisaka M, Haruta M, Komohara, et al. Therapy of primary and metastatic liver cancer by human iPS cell-derived myeloid cells producing interferon-β. J Hepatobiliary Pancreat Sci. 2017;24(2):109-119. doi:10.1002/jhbp.422 

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs